LV= has revealed that two-thirds of female cancer claims relate to breast cancer ahead of October's Breast Cancer Awareness month.
Breast cancer is the most commonly claimed for condition among men and women amounting to almost a quarter (24%) of claims, Aviva has revealed.
A new cancer drug which targets secondary breast cancer has been rejected by the National Institute of Clinical Excellence (NICE) due to its high cost.
One in 3 women diagnosed with breast cancer in England each year are aged 70 or over, a Public Health England campaign has warned.
Young black women in the UK diagnosed with breast cancer aged 40 or younger have poorer overall survival than white women in the same age group, according to a Cancer Research UK study.
Friends Life has urged women of all ages to ensure that they are ‘breast aware', as women under the age of forty accounted for 25% of all breast cancer claims it paid out last year.
To help raise awareness during Breast Cancer Awareness Month in October, Aegon has shared previously unpublished figures on breast cancer claims in 2012.
Survival estimates for those diagnosed with breast cancer have nearly doubled since 1971, with the majority of women diagnosed surviving for five years or more, research has found.
Bupa has launched a new breast cancer network to provide customers with greater access to specialist care and fast treatment.
Zurich has enhanced its Critical Illness (CI) product including improved protection for patients with breast cancer and partial payments on 6 medical conditions.